Title : Zalcitabine. A review of its pharmacology and clinical potential in acquired immunodeficiency syndrome (AIDS).

Pub. Date : 1992 Oct

PMID : 1281077






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In clinical trials, p24 antigen levels decreased and CD4 cell counts increased in patients with acquired immunodeficiency syndrome (AIDS) receiving zalcitabine > or = 0.03 mg/kg/day as monotherapy. Zalcitabine transmembrane p24 trafficking protein 2 Homo sapiens